bit.bio
Industry
- Biotechnology
- Drug Discovery Technologies
- Gene Therapy, Cell Therapy
- Research, Analytical Equipment & Supplies
- Pharmaceuticals
Latest on bit.bio
The idea of manipulating biology to produce therapeutics is not new. In 1978, Eli Lilly and Company and Genentech, Inc. developed the first recombinant DNA human insulin by inserting the human gen
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Biogen’s Pact With AbCellera Will Focus
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Novartis And Ionis Build On Earlier Akc
The second quarter of 2023 was a good news bad news situation for venture capital investment in biopharmaceutical companies, according to the latest Venture Monitor report from Pitchbook and the Natio